![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.155 | 3.43% | 4.675 | 4.35 | 5.00 | - | 25,623 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.52 | 9.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/4/2020 09:11 | 59p to buy. | ![]() bmnsa | |
27/4/2020 09:08 | Why was that video done with Fincap? PR piece for them, surely the home programme mentioned in it should have been RNS’d to the market rather than them getting heads up first and then it not being announced. | ![]() talk2dubya | |
27/4/2020 09:07 | Paradise - there was also the shoddily arranged placing, I don’t blame Landsdowne for taking profit if it is also them selling this morning. | ![]() talk2dubya | |
27/4/2020 09:05 | Too much competition out there imo, makes for a volatile share price First past the post and all that. Needs some news, and fast !! | ![]() paradise city | |
27/4/2020 09:05 | Turning up slightly now. | ![]() bmnsa | |
27/4/2020 09:04 | Looks like 56p was the support. | ![]() 2nell | |
27/4/2020 09:00 | Dropping like a stone all morning Can buy under 57p now. | ![]() bmnsa | |
27/4/2020 08:58 | Don't need PR unless you are trading. The trial will be the only important PR we need. | ![]() blueblood | |
27/4/2020 08:54 | 57,35p bags some great shares today. Lots of small sellers. edit- 57p to buy now. | ![]() bmnsa | |
27/4/2020 08:51 | Patience is a virtue. I'm comfortable here. We will all be laughing when an RNS drops and the those words come up on day traders screens "sorry we were unable to get you a quote" imo | slinkyj | |
27/4/2020 08:47 | Where is everyone this morning ? | ![]() cambradjones | |
27/4/2020 08:30 | Need to get more PR out there imo ! | ![]() paradise city | |
27/4/2020 08:30 | Would be Lansdowne again then... | ![]() markinvestor | |
27/4/2020 08:22 | Here we go, the usual early morning markdown. | ![]() cambradjones | |
27/4/2020 08:17 | Buying at just over 61p:)) | ![]() bmnsa | |
27/4/2020 08:11 | Agree talk2dubya! | ![]() hazl | |
27/4/2020 08:03 | Slinky - I think it’s relevant though to those who are getting impatient here. News could drop anytime on trials abroad and/or licensing / venture agreements. | ![]() talk2dubya | |
27/4/2020 08:01 | Ok cool, just came up on my last 24 hour search that's all. Not seen that one before. | slinkyj | |
27/4/2020 07:58 | Slink, Sorry, that report has been out ages, shared amongst many news sites. | ![]() makendon | |
27/4/2020 07:57 | Anyone know what this article may be pointing at from the world news? 15 hours ago · Synairgen is a UK-based company, and it appears their formulation hasn't crossed overseas yet. But it does say has been approached by, and is in discussion with, ...When I click on this in google it goes to error 500. Is it news about to be released? | slinkyj | |
27/4/2020 06:24 | Some overnight news on the sector - SANTHERA PHARMA - Santhera, Cold Spring Harbor Laboratory to test experimental drug lonodelestat as treatment to prevent Covid-19-related acute respiratory distress syndrome. Lonodelestat is a human neutrophil elastase inhibitor, and preventing production of that enzyme may interrupt the severe inflammatory response that leads to the acute respiratory distress | ![]() markinvestor | |
26/4/2020 19:51 | “They have given me a nebuliser and I have to do tests every 24 hours as part of the research.” This also tallies with which Marsden said in the last proactive interview where they test the sputum once a day. | ![]() adman50 | |
26/4/2020 19:50 | I only concluded it was SNG because they said it was for a trial of 100 patients. | ![]() adman50 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions